Drug Topics
AUGUST 21, 2024
Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.
Pharmacy Times
AUGUST 23, 2024
The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 23, 2024
I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.
Fierce Healthcare
AUGUST 20, 2024
Health IT giant Epic is pushing ahead rapidly to build out artificial intelligence technologies and generative AI features in its electronic health record software. | The goal, according to Epic executives, is to ease the documentation burden for clinicians, streamline charting and coding and bring evidence-based medical insights and research right to doctors' fingertips at the point of care.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
AUGUST 19, 2024
The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.
Pharmacy Times
AUGUST 20, 2024
Palliative pharmacists are invaluable assets of oncologic care.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Pharma
AUGUST 23, 2024
Bayer’s latest round of layoffs has reportedly hit Basel, Switzerland, home of the international headquarters of the company's consumer health division. | The layoffs are the latest in Bayer's massive restructuring plan that has so far impacted more than 3,000 staffers since the start of the year.
Drug Topics
AUGUST 21, 2024
Increased incidence of typed 2 diabetes was associated with higher consumption of processed meat, unprocessed red meat, and poultry.
Pharmacy Times
AUGUST 18, 2024
Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.
STAT
AUGUST 21, 2024
Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly cruel after a second IVF transfer. She and her husband, Ben Burnham, were devastated, physically and financially drained — and deeply frustrated by the lack of answers or support for people like them who had experienced recurrent miscarriages.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
AUGUST 20, 2024
Regulators in both the U.S. and Europe have looked into the potential link between suicidal thoughts and Novo Nordisk’s blockbuster semaglutide franchise after reports sounded the alarm last year. | Researchers found that users of Novo's semaglutide who were logged in a WHO database were more likely to report suicidal ideation.
Drug Topics
AUGUST 23, 2024
Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.
Pharmacy Times
AUGUST 19, 2024
The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.
STAT
AUGUST 22, 2024
WASHINGTON — U.S. regulators approved updated Covid-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter, too. With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its updated vaccine version to be available a little later.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
AUGUST 23, 2024
The healthcare industry confronts a complex, double-barreled challenge as it tries to combat the recent deluge of dangerous and damaging cyberattacks. | Cyber resilience is the ability to recognize threats, respond to them, recover quickly and at scale. The clear goal: fending off attacks more efficiently, limiting damage and restoring normal operations with minimal impact to patients.
Drug Topics
AUGUST 21, 2024
A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.
Pharmacy Times
AUGUST 17, 2024
New payment frameworks are emerging, but pharmacists need to be central to the ongoing food as medicine movement.
STAT
AUGUST 20, 2024
Last week, a mask ban in Nassau County, New York was signed into law. If I lived just 60 miles east of my New Jersey town, I would be under threat of a fine or jail time every time I left the house. I’ve been masking consistently in public since 2020, when the Covid-19 pandemic began, because I have a kidney transplant and will take immunosuppressant medication for the rest of my life.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
AUGUST 20, 2024
As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is expanding the scope of its scrutiny on China's biopharma ecosystem. | As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is expanding the scope of its scrutiny on China's biopharma ecosystem.
Drug Topics
AUGUST 21, 2024
Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.
Pharmacy Times
AUGUST 20, 2024
Jasmine Perry discusses the More Than a Script program in an interview with Pharmacy Times.
STAT
AUGUST 20, 2024
Eli Lilly’s obesity drug Zepbound significantly cut the risk of developing type 2 diabetes, showing the benefits of long-term use of the blockbuster therapy. In a Phase 3 trial that lasted over three years, people with pre-diabetes taking Zepbound had a 93% lower risk of progressing to diabetes compared with people on placebo, Lilly said Tuesday.
pharmaphorum
AUGUST 19, 2024
Walgreens has signed a $100m contract with the US government's BARDA agency for access to its decentralised clinical trials network
Drug Topics
AUGUST 22, 2024
Novavax is still awaiting FDA authorization for their protein-based COVID-19 vaccine.
Pharmacy Times
AUGUST 18, 2024
Sara Roszak discusses her role as president of the NACDS Foundation.
STAT
AUGUST 19, 2024
Private equity firms are sucking the resources out of America’s hospitals and nursing homes, and feeding on doctors to generate profits. These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.
Fierce Healthcare
AUGUST 22, 2024
Employers are actively seeking out alternatives to curb rising health benefit costs by sidestepping traditional carriers, a new report from Brighton Health Plan Solutions shows. | A new report highlights a business opportunity for providers and health systems to engage in direct contracting.
Drug Topics
AUGUST 21, 2024
The National Association of Chain Drug Stores is active at both the federal and state levels in advocating for PBM reform.
Pharmacy Times
AUGUST 19, 2024
Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.
STAT
AUGUST 19, 2024
The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients, but suffering often doesn’t just afflict the patient. It can blanket an entire household, burdening spouses and other family members with stress and anxiety and the exhausting routine of treating a life-threatening disease. But while standards exist for assessing and managing distress in patients, it’s often “hidden” in family members, sometimes with devastating
Fierce Healthcare
AUGUST 20, 2024
The upward trajectory of Medicare Advantage (MA) enrollment is likely to become an issue for hospitals and other healthcare providers forced to contend with plans’ prior authorization requirements | Prior authorization burdens and "a challenging contract negotiation season" on the horizon are likely headwinds for providers, and hospitals in particular, according to a recent report.
pharmaphorum
AUGUST 20, 2024
GSK gets FDA breakthrough status for its B7-H3 directed ADC, licensed from Hansah Pharma in a $1.
Pharmacy Times
AUGUST 23, 2024
Bendamustine resulted in a greater risk of treatment complications in patients with lymphoma.
Expert insights. Personalized for you.
112 
Let's personalize your content